BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 27249723)

  • 1. Biliary Tract Cancer: Epidemiology, Radiotherapy, and Molecular Profiling.
    Bridgewater JA; Goodman KA; Kalyan A; Mulcahy MF
    Am Soc Clin Oncol Educ Book; 2016; 35():e194-203. PubMed ID: 27249723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial Risk of Biliary Tract Cancers: A Population-Based Study in Utah.
    Samadder NJ; Smith KR; Wong J; Hanson H; Boucher K; Burt RW; Charlton M; Byrne KR; Gallegos-Orozco JF; Koptiuch C; Curtin K
    Dig Dis Sci; 2016 Dec; 61(12):3627-3632. PubMed ID: 27655103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic KRAS-expressing organoids with biliary epithelial stem cell properties give rise to biliary tract cancer in mice.
    Kasuga A; Semba T; Sato R; Nobusue H; Sugihara E; Takaishi H; Kanai T; Saya H; Arima Y
    Cancer Sci; 2021 May; 112(5):1822-1838. PubMed ID: 33068050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age trends in biliary tract cancer incidence by anatomical subtype: A Swedish cohort study.
    Rahman R; Ludvigsson JF; von Seth E; Lagergren J; Bergquist A; Radkiewicz C
    Eur J Cancer; 2022 Nov; 175():291-298. PubMed ID: 36174301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical, epidemiological and therapeutic features of biliary tract cancers: about 20 cases].
    Ka I; Faye M; Diop PS; Faye ABNAC; Ndoye JM; Fall B
    Pan Afr Med J; 2018; 29():13. PubMed ID: 29662598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic Profiling of Biliary Tract Cancers and Implications for Clinical Practice.
    Jain A; Kwong LN; Javle M
    Curr Treat Options Oncol; 2016 Nov; 17(11):58. PubMed ID: 27658789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiologic patterns of biliary tract cancer in the United States: 2001-2015.
    Koshiol J; Yu B; Kabadi SM; Baria K; Shroff RT
    BMC Cancer; 2022 Nov; 22(1):1178. PubMed ID: 36384474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epidemiological trends of biliary tract cancers in the United States of America.
    Jiang Y; Jiang L; Li F; Li Q; Yuan S; Huang S; Fu Y; Yan X; Chen J; Li H; Li S; Liu J
    BMC Gastroenterol; 2022 Dec; 22(1):546. PubMed ID: 36581813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gallbladder and bile duct carcinoma. Biology and pathology].
    Tannapfel A; Wittekind C
    Internist (Berl); 2004 Jan; 45(1):33-41. PubMed ID: 14735242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological characteristics of cancers in the gallbladder and biliary tract and targeted therapy.
    Thomas MB
    Crit Rev Oncol Hematol; 2007 Jan; 61(1):44-51. PubMed ID: 17164111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biliary tract cancers in Olmsted County, Minnesota, 1976-2008.
    Yang JD; Kim B; Sanderson SO; Sauver JS; Yawn BP; Larson JJ; Therneau TM; Roberts LR; Gores GJ; Kim WR
    Am J Gastroenterol; 2012 Aug; 107(8):1256-62. PubMed ID: 22751468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and Overall Survival of Biliary Tract Cancers in South Korea from 2006 to 2015: Using the National Health Information Database.
    Kim BW; Oh CM; Choi HY; Park JW; Cho H; Ki M
    Gut Liver; 2019 Jan; 13(1):104-113. PubMed ID: 29938462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Proton Pump Inhibitor Use and Biliary Tract Cancer Risk: A Swedish Population-Based Cohort Study.
    Kamal H; Sadr-Azodi O; Engstrand L; Brusselaers N
    Hepatology; 2021 Oct; 74(4):2021-2031. PubMed ID: 34018229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
    Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
    Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers.
    Nakazawa K; Dobashi Y; Suzuki S; Fujii H; Takeda Y; Ooi A
    J Pathol; 2005 Jul; 206(3):356-65. PubMed ID: 15892172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted therapies in advanced biliary tract cancers-a narrative review.
    LaPelusa M; Heumann T; Goff L; Agarwal R
    Chin Clin Oncol; 2023 Apr; 12(2):14. PubMed ID: 36946186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biliary tract cancer incidence and trends in the United States by demographic group, 1999-2013.
    Van Dyke AL; Shiels MS; Jones GS; Pfeiffer RM; Petrick JL; Beebe-Dimmer JL; Koshiol J
    Cancer; 2019 May; 125(9):1489-1498. PubMed ID: 30645774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary and adjuvant radiation therapy in gallbladder and extrahepatic biliary tract carcinoma.
    Kopelson G; Gunderson LL
    J Clin Gastroenterol; 1983 Feb; 5(1):43-50. PubMed ID: 6841948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological aspects of biliary tree tumors in a region of northern Italy: emerging trends and sex-based differences.
    Floreani A; Lisiero M; Baldovin T; Baldo V
    Eur J Gastroenterol Hepatol; 2013 Nov; 25(11):1347-51. PubMed ID: 24081106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant Therapy for Biliary Tract Cancers.
    Horgan AM; Knox JJ
    J Oncol Pract; 2018 Dec; 14(12):701-708. PubMed ID: 30537458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.